Documents › 04395f40842342f0bd1f17daa54b180499370da4:872-922

464 - POST2313715_Jaime Bermudez_10.17.2024 POSAAB Transcript.pdf

POST board hearing transcriptboard proceeding 2024-11-21 51 pages (file pages 872–922) original file
About this document
Layer
packet: an item in a POST meeting packet
Type as titled
transcript (kind from title)
File
04395f40842342f0bd1f17daa54b180499370da4 application/pdf
Cases
POST 2313715 · Jaime Bermudez (packet item)

About: Jaime Bermudez (case)

Page 28 · file page 899 larger image
Image of page 28; its text is alongside
Text: digital text layer
   241
KATHRYN S. SWANK, CSR, RPR    (916) 390-7731
POSAAB Meeting, October 17, 2024
same type of biological testing.
THC is inclusive in many of those tests.
There are also another range of -- there's a full
range of controlled substances that are randomly tested
for, depending on the profession you're testing.
So I won't go into too much detail because I know
time is of the essence, but the one thing I think I
spoke to our Chair about today, was that there's the
drug of choice which is the drug that they were found to
have in their -- under the influence of, when the
discipline occurred.
And then there's the what they call the drug of
convenience, which is what they will come in contact
with or be exposed to.
So, we test for both.
We're not testing for the substance, we're testing
for the addiction.  And that is part of our public
protection role as a licensing agency.
MEMBER CLAVO:  One more question.  Be quick.
BOARD CHAIR DUDLEY:  And Ms. Del Mugnaio also tells
me something else, which the drug of convenience, a good
way to think about that, is doctors have an ability to
get prescription drugs, so even though it might not be
their drug of choice, it may be the drug of convenience.
Next comment.
 1
 2
 3
 4
 5
 6
 7
 8
 9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
899

Keys: ← → or j k turn pages; / finds.